Bromilow J, Schuster Bruce M J L
Intensive Care Unit, Royal Perth Hospital, Perth, Western Australia, Australia.
Anaesth Intensive Care. 2007 Apr;35(2):256-8. doi: 10.1177/0310057X0703500215.
The incidence of sepsis is increasing and remains the leading cause of death in critically ill patients. The statin group of drugs appear to have important anti-inflammatory effects and may have a role in the treatment of sepsis. However, current prescribing guidelines recommend that statin therapy is discontinued in critically ill patients. We found no evidence to support commencing statin therapy in patients with sepsis on an intensive care unit and low levels of evidence to support continuing established therapy in this patient population.
脓毒症的发病率正在上升,并且仍然是重症患者死亡的主要原因。他汀类药物似乎具有重要的抗炎作用,可能在脓毒症治疗中发挥作用。然而,目前的处方指南建议在重症患者中停用他汀类药物治疗。我们没有发现证据支持在重症监护病房的脓毒症患者中开始他汀类药物治疗,且仅有低水平证据支持在该患者群体中继续已有的治疗。